Universal testing for COVID-19 in patients undergoing cancer treatment during the second outbreak in Brescia

The impact of coronavirus disease 2019 (COVID-19) has been overwhelming on patients with cancer, who may be at higher risk of developing severe disease. During the second COVID-19 outbreak in Italy, we planned universal microbiologic screening for patients scheduled for antineoplastic treatment.All patients with planned active treatment at Brescia University Radiation Oncology Department were screened for severe acute respiratory syndrome...